Seeks to acquire a pharmaceutical business and combine it with investor funds and securities.
10-K for FY2025, filed Apr 15, 2026
No revenue reported yet.
10-K for FY2025, filed Apr 15, 2026
10-Q for Q2 FY2026, filed Aug 14, 2026
$4.4MView ↗
Loading...